867
Clinicians who manage cachectic patients, particularly those with protracted diarrhoea and/or receiving anti-malarial drugs including mefloquine, should be aware of the risk of severe hypoglycaemia.
 cachectic patients: Subject; with protracted diarrhoea: Subject; severe hypoglycaemia: Effect; anti-malarial drugs including mefloquine: Treatment; mefloquine: Treatment.Drug; cachectic: Treatment.Disorder; protracted diarrhoea: Treatment.Disorder
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 cachectic patients: Subject; with protracted diarrhoea: Subject; severe hypoglycaemia: Effect; anti-malarial drugs including mefloquine: Treatment; mefloquine: Treatment.Drug; cachectic: Treatment.Disorder; protracted diarrhoea: Treatment.Disorder